GlaxoSmithKline S.A.E. (BIOC.CA)

Also known as:  GSK Egypt, GlaxoSmithKline Egypt
Data delayed by 15 minutes
27.36 EGP 0.000.00%
As of 19 JAN 2022 - GMT|Egypt SE

GSK Egypt Stock Price & Performance Powered By Knowledge Direct

Recommendation
-
Div Yield
1.736%
P/E (Last 12 Month)
0.0
Upside
-
Target Price (Mean)
-
52Wk
26.93 17 JAN
33.25 02 JAN

Open
Data not available
Previous Close
27.36 EGP
Turnover
Data not available
EPS
-
Volume
0
Transactions
0
Market Cap
2.28B EGP
IPO Date
01-Sep-1993
Analyst Recommendation
Sell
Hold
Buy
Analyst Rating
Strong Buy
Buy
Hold
Sell
Strong Sell

About GlaxoSmithKline S.A.E.

Country of Incorporation
Established In
1981
Primary Sector
Stock Listing
IDStock TypeCurrencyExchangeSymbol
BIOC.CASEOrdinaryEGPEgypt SEBIOC

Contact details

Primary address
Building: Boomerang Building 46, Block J
Street: Ninety Street
Floor: 1st-3rd Floor
Area: 5th Settlement
P.O. Box: 41
Country: Egypt
City: Cairo
City Suffix: 11835
CONTACT
    Region
    Cairo
    More
    All Health Care News
    All Markets News

    Ownership

    Revenue
    Net Income
    Profit Margin
    Total Assets
    Total Liabilities
    Debt to Assets
    Operating
    Investing
    Financing

    Company information provided by Refinitiv

    Refinitiv research team update company information from primary sources (company annual reports, press releases, company websites, corporate briefings, official statements/interviews) and reliable secondary sources (stock markets, reliable third party publications).

    Peers

    StocksLast Price% Change
    ADVANCED PHARMA1.250 EGP0.00
    MEDICAL PACK0.381 EGP0.00
    ALX. PHARMACEUT.106.330 EGP0.00
    CLEOPATRA HOSP5.000 EGP0.00
    EGYPT INTL PHRM41.060 EGP0.00
    ARAB PHARM52.560 EGP0.00
    More

    Thursday Outlook: Asian shares rise; oil prices ease from 2014 high

    Thursday Outlook: Asian shares rise; oil prices ease from 2014 high

    Gold jumps 1% on subdued dollar, palladium bounces 7%

    More

    Most Viewed Stocks

    Stock Screener

    More